SCHEMBL19148959

SCHEMBL19148959

Fc1ccc2c(C(F)F)cc(C(F)F)nc2c1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 5/20 0.36
▸ MPO P05164 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.34
▸ KMT2A Q03164 1/20 0.33
▸ AAK1 Q2M2I8 2/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ KCNH2 Q12809 2/20 0.32
▸ BCHE P06276 3/20 0.31
▸ PARP14 Q460N5 1/20 0.31
▸ CYP11B1 P15538 1/20 0.31
▸ CYP11B2 P19099 1/20 0.31
▸ C1R P00736 1/20 0.31
▸ BACE1 P56817 1/20 0.31
▸ PDE5A O76074 1/20 0.30
▸ ALPL P05186 1/20 0.30
▸ ALPI P09923 1/20 0.30
▸ ALPG P10696 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19150073 0.86 DHODH (0.37) ACHEMPOKDM4ETDP1L3MBTL1
SCHEMBL19150086 0.82 POLB (0.43) ACHEMPOKMT2AAAK1BCHE
SCHEMBL19150089 0.78 KDM4E (0.39) KDM4EAAK1C1RBACE1
SCHEMBL19148212 0.78 ADORA2A (0.46) ACHEMPOKDM4EKMT2AAAK1
SCHEMBL3291837 0.78 TDP1 (0.43) ACHEKDM4EKMT2ATDP1L3MBTL1
SCHEMBL19148203 0.77 APP (0.44) KDM4ETDP1L3MBTL1PARP14
SCHEMBL19148598 0.77 KDM4E (0.41) ACHEMPOKDM4EKMT2AL3MBTL1
SCHEMBL19150095 0.75 BCHE (0.37) ACHEMPOKDM4EBCHECYP11B1
SCHEMBL19149253 0.74 NPC1 (0.38) AAK1
SCHEMBL19149180 0.68 EPRS1 (0.36) KDM4EKMT2ATDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10266494-B2 Process for the preparation of polyfluoroalkylated quinolines BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-04-23 — — US disclosed
US-20190023659-A1 PROCESS FOR THE PREPARATION OF POLYFLUOROALKYLATED QUINOLINES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-01-24 — — US disclosed
EP-3405458-A1 PROCESS FOR THE PREPARATION OF POLYFLUOROALKYLATED QUINOLINES Bayer CropScience Aktiengesellschaft (DE) 2018-11-28 — — EP disclosed
WO-2017125318-A1 PROCESS FOR THE PREPARATION OF POLYFLUOROALKYLATED QUINOLINES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-07-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190023659-A1 PROCESS FOR THE PREPARATION OF POLYFLUOROALKYLATED QUINOLINES KCNQ1, KCNQ2, KCNQ4 ACHE 1281/4885MPO 979/4885KDM4E 420/4885
US-10266494-B2 Process for the preparation of polyfluoroalkylated quinolines KCNQ1, KCNQ2, KCNQ4 ACHE 1281/4885MPO 979/4885KDM4E 420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback